UNITEDHEALTH GROUP INC
UNHAPI behind this page
UNH Q1 2026 request
Playground key active
/api/financials?ticker=UNH&year=2026&quarter=1
Pick an endpoint and run the request.
Income Statement
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Premiums Earned Net | 87,561 | 86,534 | +1.2% |
Show Business Segments breakouts |
|||
| Optum Health · Operating Segments | 4,575 | 5,021 | -8.9% |
| Optum · Unaffiliated Customers | 4,575 | 5,021 | -8.9% |
| UnitedHealthcare · Operating Segments | 82,986 | 81,513 | +1.8% |
Show Major Customers breakouts |
|||
| Unaffiliated Customers | 87,561 | 86,534 | +1.2% |
| Investment Income Interest And Dividend | 1,131 | 1,033 | +9.5% |
Show Business Segments breakouts |
|||
| Optum | 627 | 505 | +24.2% |
| Optum Health · Operating Segments | 244 | 225 | +8.4% |
| Optum Insight · Operating Segments | 342 | 233 | +46.8% |
| Optum Rx · Operating Segments | 41 | 47 | -12.8% |
| UnitedHealthcare · Operating Segments | 504 | 528 | -4.5% |
Show Restructuring Cost And Reserve breakouts |
|||
| Restructuring and other actions | 74 | — | — |
| Revenue | 111,721 | 109,575 | +2.0% |
Show Business Segments breakouts |
|||
| Optum | 63,749 | 63,885 | -0.2% |
| Optum Health · Operating Segments | 8,867 | 8,802 | +0.7% |
| Optum Health · Operating Segments | 14,998 | 15,810 | -5.1% |
| Optum Health · Operating Segments | 24,109 | 24,837 | -2.9% |
| Optum Insight · Operating Segments | 1,665 | 1,703 | -2.2% |
| Optum Insight · Operating Segments | 3,118 | 3,091 | +0.9% |
| Optum Insight · Operating Segments | 5,125 | 5,027 | +1.9% |
| Optum Rx · Operating Segments | 14,297 | 13,948 | +2.5% |
| Optum Rx · Operating Segments | 21,398 | 21,137 | +1.2% |
| Optum Rx · Operating Segments | 35,736 | 35,132 | +1.7% |
| Optum · Affiliated Customers | 38,293 | 38,927 | -1.6% |
| Optum · Unaffiliated Customers | 24,829 | 24,453 | +1.5% |
| UnitedHealthcare · Operating Segments | 85,761 | 84,089 | +2.0% |
| UnitedHealthcare · Operating Segments | 86,265 | 84,617 | +1.9% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -38,293 | -38,927 | +1.6% |
| Corporate Non Segment · Affiliated Customers | -38,293 | -38,927 | +1.6% |
| Intersegment Elimination | -1,221 | -1,111 | -9.9% |
| Intersegment Elimination · Affiliated Customers | -1,221 | -1,111 | -9.9% |
Show Major Customers breakouts |
|||
| Unaffiliated Customers | 110,590 | 108,542 | +1.9% |
| Revenue (Q) | — | — | — |
Show Product Lines breakouts |
|||
| Product | 13,250 | 13,036 | +1.6% |
| Product · Optum | 13,250 | 13,036 | +1.6% |
| Product · Optum Health | 57 | 65 | -12.3% |
| Product · Optum Insight | 45 | 44 | +2.3% |
| Product · Optum Rx | 13,148 | 12,927 | +1.7% |
| Product · Unaffiliated Customers | 13,250 | 13,036 | +1.6% |
| Service | 9,779 | 8,972 | +9.0% |
| Service · Optum | 7,004 | 6,396 | +9.5% |
| Service · Optum Health | 4,235 | 3,716 | +14.0% |
| Service · Optum Insight | 1,620 | 1,659 | -2.4% |
| Service · Optum Rx | 1,149 | 1,021 | +12.5% |
| Service · Unaffiliated Customers | 9,779 | 8,972 | +9.0% |
| Service · UnitedHealthcare | 2,775 | 2,576 | +7.7% |
| Policyholder Benefits And Claims Incurred Net | 73,489 | 73,411 | +0.1% |
| Selling, General & Administrative | 15,390 | 13,594 | +13.2% |
Show Restructuring Cost And Reserve breakouts |
|||
| Restructuring and other actions | 415 | — | — |
| Cost of Revenue | 12,823 | 12,390 | +3.5% |
| Depreciation And Amortization | 1,029 | 1,061 | -3.0% |
Show Business Segments breakouts |
|||
| Optum | 811 | 842 | -3.7% |
| Optum Health · Operating Segments | 246 | 255 | -3.5% |
| Optum Insight · Operating Segments | 392 | 376 | +4.3% |
| Optum Rx · Operating Segments | 173 | 211 | -18.0% |
| UnitedHealthcare · Operating Segments | 218 | 219 | -0.5% |
| Total Costs & Expenses | 102,731 | 100,456 | +2.3% |
Show Business Segments breakouts |
|||
| Optum | 60,453 | 59,992 | +0.8% |
| Optum Health · Operating Segments | 22,968 | 23,426 | -2.0% |
| Optum Insight · Operating Segments | 4,162 | 3,863 | +7.7% |
| Optum Rx · Operating Segments | 34,544 | 33,814 | +2.2% |
| UnitedHealthcare · Operating Segments | 80,571 | 79,391 | +1.5% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -38,293 | -38,927 | +1.6% |
| Intersegment Elimination | -1,221 | -1,111 | -9.9% |
| Operating Income | 8,990 | 9,119 | -1.4% |
Show Business Segments breakouts |
|||
| Optum | 3,296 | 3,893 | -15.3% |
| Optum Health · Operating Segments | 1,141 | 1,411 | -19.1% |
| Optum Insight · Operating Segments | 963 | 1,164 | -17.3% |
| Optum Rx · Operating Segments | 1,192 | 1,318 | -9.6% |
| UnitedHealthcare · Operating Segments | 5,694 | 5,226 | +9.0% |
| Interest Expense | -955 | -998 | +4.3% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -955 | -998 | +4.3% |
| Loss On Sale Of Subsidiary And Subsidiaries Held For Sale | -72 | -15 | -380.0% |
Show Business Segments breakouts |
|||
| UnitedHealthcare · Operating Segments | -72 | -15 | -380.0% |
| Income Before Taxes | 7,963 | 8,106 | -1.8% |
Show Business Segments breakouts |
|||
| Optum | 3,296 | 3,893 | -15.3% |
| Optum Health · Operating Segments | 1,141 | 1,411 | -19.1% |
| Optum Insight · Operating Segments | 963 | 1,164 | -17.3% |
| Optum Rx · Operating Segments | 1,192 | 1,318 | -9.6% |
| UnitedHealthcare · Operating Segments | 5,622 | 5,211 | +7.9% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -955 | -998 | +4.3% |
| Income Tax Expense (Benefit) | -1,482 | -1,632 | +9.2% |
| Net Income | 6,481 | 6,474 | +0.1% |
| Net Income Loss Attributable To Noncontrolling Interest | -201 | -182 | -10.4% |
| Net Income | 6,280 | 6,292 | -0.2% |
Show Equity Components breakouts |
|||
| Retained Earnings | 6,280 | 6,292 | -0.2% |
| EPS (Basic) | 6.92 | 6.9 | +0.3% |
| EPS (Diluted) | 6.9 | 6.85 | +0.7% |
| Wtd Avg Shares (Basic) | 908 | 912 | -0.4% |
| Weighted Average Number Diluted Shares Outstanding Adjustment | 2 | 6 | -66.7% |
| Wtd Avg Shares (Diluted) | 910 | 918 | -0.9% |
| Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount | 18 | 6 | +200.0% |
| Comprehensive Income | 5,779 | 6,774 | -14.7% |
| Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 | 73,489 | 73,411 | +0.1% |
Show Restructuring Cost And Reserve breakouts |
|||
| Restructuring and other actions | 137 | — | — |
Balance Sheet
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 28,001 | 30,717 | -8.8% |
| Short-Term Investments | 3,228 | 3,574 | -9.7% |
| Accounts Receivable | 26,587 | 26,936 | -1.3% |
Show Product Lines breakouts |
|||
| unh:ProductsandservicesMember | 9.3 | 11.7 | -20.5% |
| Other Receivables Net Current | 24,588 | 26,022 | -5.5% |
| Prepaid Expenses & Other Current Assets | 8,723 | 9,036 | -3.5% |
| Total Current Assets | 91,127 | 96,285 | -5.4% |
| Non-Current Assets | |||
| Long Term Investments | 56,788 | 51,863 | +9.5% |
| Property, Plant & Equipment | 10,667 | 10,734 | -0.6% |
| Goodwill | 110,512 | 107,566 | +2.7% |
| Other Non-Current Assets | 23,457 | 20,395 | +15.0% |
| Total Assets | 312,644 | 309,790 | +0.9% |
Show Business Segments breakouts |
|||
| Optum | 195,214 | 192,571 | +1.4% |
| Optum Health · Operating Segments | 73,620 | 72,000 | +2.2% |
| Optum Insight · Operating Segments | 63,099 | 60,192 | +4.8% |
| Optum Rx · Operating Segments | 58,495 | 60,379 | -3.1% |
| UnitedHealthcare · Operating Segments | 129,027 | 131,902 | -2.2% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -11,597 | -14,683 | +21.0% |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 20,093 | 22,947 | -12.4% |
| Current Liabilities | |||
| Liability For Claims And Claims Adjustment Expense | 39,659 | 37,136 | +6.8% |
| Accounts Payable And Accrued Liabilities Current | 38,631 | 33,566 | +15.1% |
| Debt Current | 6,477 | 9,986 | -35.1% |
| Deferred Revenue | 3,419 | 3,296 | +3.7% |
| Other Liabilities Current | 25,938 | 29,487 | -12.0% |
| Total Current Liabilities | 114,124 | 113,471 | +0.6% |
| Commercial Paper (Q) | — | — | — |
Show Debt Instrument breakouts |
|||
| Commercial Paper | 3.4 | 5.2 | -34.6% |
| Non-Current Liabilities | |||
| Long-Term Debt | 71,440 | 71,285 | +0.2% |
| Deferred Tax Liabilities | 2,864 | 3,902 | -26.6% |
| Other Non-Current Liabilities | 18,897 | 15,963 | +18.4% |
| Total Liabilities | 207,325 | 204,621 | +1.3% |
| Other Liabilities | |||
| Redeemable Noncontrolling Interest Equity Carrying Amount | 1,424 | 4,358 | -67.3% |
| Stockholders' Equity | |||
| Common Stock | 9 | 9 | 0.0% |
| Additional Paid-In Capital | 556 | — | — |
| Retained Earnings | 99,878 | 97,934 | +2.0% |
| Accumulated Other Comprehensive Income | -2,562 | -2,905 | +11.8% |
| Minority Interest | 6,014 | 5,773 | +4.2% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 103,895 | 100,811 | +3.1% |
Show Equity Components breakouts |
|||
| Accumulated Net Unrealized Investment Gain Loss | -1,360 | -1,832 | +25.8% |
| Accumulated Translation Adjustment | -1,202 | -1,073 | -12.0% |
| Additional Paid In Capital | 556 | — | — |
| Common Stock | 9 | 9 | 0.0% |
| Noncontrolling Interest | 6,014 | 5,773 | +4.2% |
| Retained Earnings | 99,878 | 97,934 | +2.0% |
| Total Liabilities & Equity | 312,644 | 309,790 | +0.9% |
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.0% |
| Common Stock Shares Authorized | 3,000 | 3,000 | 0.0% |
| Common Stock Shares Issued | 908 | 910 | -0.2% |
| Common Stock Shares Outstanding | 908 | 910 | -0.2% |
Show Equity Components breakouts |
|||
| Common Stock | 908 | 910 | -0.2% |
| Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0.0% |
| Preferred Stock Shares Authorized | 10 | 10 | 0.0% |
Cash Flow Statement
| Metric | YTD Q1 2026 | YTD Q1 2025 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Deferred Income Taxes | 540 | 64 | +743.8% |
| Stock-Based Compensation | 348 | 375 | -7.2% |
| Other Non-Cash Items | -304 | 97 | -413.4% |
| Change in Accounts Receivable | -3,544 | -4,462 | +20.6% |
| Increase Decrease In Other Operating Assets | 2,919 | -544 | +636.6% |
| Increase Decrease In Health Care Insurance Liabilities | 296 | 2,993 | -90.1% |
| Increase Decrease In Accounts Payable And Accrued Liabilities | 1,055 | -607 | +273.8% |
| Increase Decrease In Deferred Revenue | 20 | -10 | +300.0% |
| Net Cash from Operations | 8,912 | 5,456 | +63.3% |
| Investing Activities | |||
| Payments To Acquire Investments | -6,515 | -4,135 | -57.6% |
| Proceeds From Sale Of Available For Sale Securities Debt | 1,878 | 3,185 | -41.0% |
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | 2,285 | 2,167 | +5.4% |
| Capital Expenditures | -763 | -898 | +15.0% |
| Repayments Of Care Provider Loans Cyberattack | 82 | 891 | -90.8% |
| Originations And Purchases Of Loans | -1,215 | -833 | -45.9% |
| Repayments And Maturities Of Loans | 699 | 254 | +175.2% |
| Proceeds From Divestiture Of Businesses | 1,081 | 21 | +5047.6% |
Show Disposal Group Classification breakouts |
|||
| Disposition | 1.1 | — | — |
| Other Investing Activities | 21 | -24 | +187.5% |
| Net Cash from Investing | -2,447 | -74 | -3206.8% |
| Financing Activities | |||
| Payments Of Dividends Common Stock | -2,005 | -1,912 | -4.9% |
| Proceeds From Issuance Of Common Stock | 231 | 360 | -35.8% |
| Repayments Of Long Term Debt | -1,500 | — | — |
| Proceeds From Repayments Of Commercial Paper | 1,100 | 3,911 | -71.9% |
| Increase Decrease In Deposits | 600 | 1,245 | -51.8% |
| Proceeds From Payments For Other Financing Activities | -1,418 | -505 | -180.8% |
| Net Cash from Financing | -2,992 | 99 | -3122.2% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -7 | 15 | -146.7% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations | 3,466 | 5,496 | -36.9% |
| Increase In Cash Within Businesses Held For Sale | 170 | -91 | +286.8% |
| Net Change in Cash | 3,636 | 5,405 | -32.7% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 28,001 | 30,717 | -8.8% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.